or
forgot password
  • cancer clinical trials in sioux city, IA

  • Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Siouxland Hematology Oncology Associates
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Breast Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Siouxland Hematology-Oncology Assoc., Llp
    Sioux City, Iowa 51101
    Prostate Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Siouxland Hematology Oncology Associates
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Brain and Central Nervous System Tumors
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Siouxland Hematology - Oncology Associates
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Brain and Central Nervous System Tumors
    Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Brain and Central Nervous System Tumors
    Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Leukemia, Lymphoma
    Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Breast Cancer
    Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Anal Cancer, Carcinoma of the Appendix, Colorectal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Liver Cancer, Nausea and Vomiting, Pancreatic Cancer, Primary Peritoneal Cavity Cancer, Small Intestine Cancer
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Lung Cancer
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Siouxland Hematology and Oncology Associates LLP
    Sioux City, Iowa 51101
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Carcinoma of Unknown Primary
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Saint Luke's Regional Medical Center

    Trial Locations
    Saint Luke's Regional Medical Center
    Siouxland Hematology Oncology Associates
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Lung Cancer